TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Hisamitsu Pharmaceutical Co ( (JP:4530) ) has issued an update.
Hisamitsu Pharmaceutical Co. has finalized the details of stock compensation-type share options, initially resolved by the Board of Directors on July 10, 2025. The allocation involves 141 stock acquisition rights priced at 318,600 yen each, calculated using the Black-Scholes model based on the Tokyo Stock Exchange’s closing price. These rights are designated for six directors of the company, excluding outside directors, and are intended to align their interests with the company’s performance.
More about Hisamitsu Pharmaceutical Co
YTD Price Performance: -1.50%
Average Trading Volume: 157,206
Technical Sentiment Signal: Sell
Current Market Cap: Yen290.5B
For detailed information about 4530 stock, go to TipRanks’ Stock Analysis page.